Morgan Stanley has upgraded Vir Biotechnology ( VIR, Financial) and uplifted its price target for the stock to $20 from ...

Global brokerage Goldman Sachs on Thursday lowered its target price for Reliance Industries Ltd (RIL), while maintaining 'buy' rating for the diversified group. The brokerage reduced RIL's target ...

Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan ...

Veeva share price has recently been battling concerns that Salesforce will become a more aggressive competitor and take ...

Indian benchmark equity indices, Sensex and Nifty50, opened lower on Thursday, reflecting negative signals from global ...

Two Morgan Stanley analysts have outlined bull-case target prices that imply substantial upside for Datadog and Arm ...

Morgan Stanleys Chief US Equity Strategist, Mike Wilson, forecasts a volatile first half of 2025, with recovery prospects ...

Reliance Industries' stock valuation hits a 3-year low, offering a strong risk-reward opportunity. Analysts foresee growth in ...

Morgan Stanley closed $8.38 short of its 52-week high ($136.24), which the company achieved on November 25th.

Shares of SolarEdge Technologies (SEDG) tumbled in mid-day trade on Wednesday after Morgan Stanley analysts reiterated their ...

The bulk of Morgan Stanley's new managing directors, or 46%, work for the investment bank.

Morgan Stanley (MS) stock saw a decline, ending the day at $126.88 which represents a decrease of $-1.76 or -1.37% from the prior close of $128.64. The stock opened at $129.65 and touched a low of ...